Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujisawa, K.
Right arrow Articles by McMillan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujisawa, K.
Right arrow Articles by McMillan, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation- dependent antigens

K Fujisawa, P Tani and R McMillan

Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.

Chronic immune thrombocytopenic purpura (ITP) is a syndrome of destructive thrombocytopenia due to autoantibodies against platelet- associated antigens. These antigens are most commonly located on the platelet glycoprotein (GP) IIb/IIIa complex. In the present studies, we show that many platelet-associated anti-GPIIb/IIIa autoantibodies from chronic ITP patients depend on conformationally intact GPIIb/IIIa for maximal binding. We studied anti-GPIIb/IIIa autoantibodies from 19 ITP patients (15 platelet-associated, 8 plasma) and alloantibodies from three patients with posttransfusion purpura (anti-PIA1). Antibodies were preincubated with purified intact GPIIb/IIIa, EDTA-dissociated GPIIb/IIIa, GPIIIa, or GPIIb for 2 hours and then residual antibody was measured in an antigen capture assay. The binding results were compared with those obtained using antibody preincubated in buffer. Of the 15 platelet-associated autoantibodies studied, the intact GPIIb/IIIa complex resulted in greater inhibition of antibody binding than the EDTA-dissociated complex, with a mean inhibition ratio (intact/dissociated) of 7.9 (range, 1.4 to 30.3). Little inhibition was noted using either GPIIb or GPIIIa. Conversely, plasma anti-PIA1 alloantibodies or plasma autoantibodies from ITP patients against the c- terminal region of GPIIIa were more efficiently inhibited by the dissociated complex or purified GPIIIa. We conclude that platelet- associated anti-GPIIb/IIIa autoantibodies in chronic ITP are frequently directed to cation-dependent conformational antigens.

Volume 81, Issue 5, pp. 1284-1289, 03/01/1993
Copyright © 1993 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
J. Kahng, H. H. Park, K. Han, B. Y. Choi, and W. Lee
Quantitative Comparisons of Antibody-Binding Sites of Platelet Glycoprotein IIb/IIIa in Aplastic Anemia and Idiopathic Thrombocytopenic Purpura
Ann. Clin. Lab. Sci., January 1, 2008; 38(1): 6 - 11.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Kosugi, Y. Tomiyama, S. Honda, H. Kato, T. Kiyoi, H. Kashiwagi, Y. Kurata, and Y. Matsuzawa
Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb
Blood, September 15, 2001; 98(6): 1819 - 1827.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Kuwana, J. Kaburaki, H. Kitasato, M. Kato, S. Kawai, Y. Kawakami, and Y. Ikeda
Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura
Blood, July 1, 2001; 98(1): 130 - 139.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. McMillan, J. Lopez-Dee, and J. C. Loftus
Autoantibodies to {alpha}IIb{beta}3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on {alpha}IIb
Blood, April 1, 2001; 97(7): 2171 - 2172.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Peterson, G. P. Visentin, P. J. Newman, and R. H. Aster
A Recombinant Soluble Form of the Integrin alpha IIbbeta 3 (GPIIb-IIIa) Assumes an Active, Ligand-Binding Conformation and Is Recognized by GPIIb-IIIa-Specific Monoclonal, Allo-, Auto-, and Drug-Dependent Platelet Antibodies
Blood, September 15, 1998; 92(6): 2053 - 2063.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Nomura, T. Matsuzaki, Y. Ozaki, M. Yamaoka, C. Yoshimura, K. Katsura, G. L. Xie, H. Kagawa, T. Ishida, and S. Fukuhara
Clinical Significance of HLA-DRB1*0410 in Japanese Patients With Idiopathic Thrombocytopenic Purpura
Blood, May 15, 1998; 91(10): 3616 - 3622.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Nardi, L.-X. Liu, and S. Karpatkin
GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia
PNAS, July 8, 1997; 94(14): 7589 - 7594.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1993 by American Society of Hematology         Online ISSN: 1528-0020